Doximity delivered strong operational performance with 20% revenue growth and substantially higher profitability while reducing share repurchases.
The company's ability to expand its physician user base to over 620,000 active providers while maintaining healthy margins demonstrates the strength of its platform and market position. The reduced share buyback activity suggests management may be prioritizing cash retention or alternative capital allocation strategies, which could indicate preparation for growth investments or changing market conditions.
Doximity showed solid financial performance with revenue growing 20% to $570.4M and gross profit expanding 21.1% to $514.5M, while operating income increased 39% and net income grew substantially. Operating cash flow strengthened notably to $273.3M, though share buybacks declined significantly from $280.7M to $120.3M. The balance sheet remained healthy with total assets growing 17.1% to $1.3B and stockholders equity expanding over 20% to $1.1B.
Buyback activity reduced 57.1% — capital being redeployed elsewhere or cash conservation underway.
Net income grew 51.2% — bottom-line growth signals improving overall business health.
Operating cash flow surged 48.4% — exceptional cash generation, highest quality earnings signal.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Receivables grew 26.7% — monitor days sales outstanding for collection efficiency.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Equity base grew 20.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Revenue growing 20% — solid top-line momentum, watch margins for quality of growth.
Current assets grew 19.2% — improving short-term liquidity or inventory/receivables build.
Asset base grew 17.1% — expansion through organic growth, acquisitions, or capital deployment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →